Should You Accumulate Reata Pharmaceuticals Inc (RETA) Stock Monday?
Monday, September 25, 2023 12:39 PM | InvestorsObserver Analysts
Mentioned in this article
Reata Pharmaceuticals Inc (RETA) stock is higher by 650.41% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives RETA stock a score of 61 out of a possible 100.
That rank is influenced by a long-term technical score of 98. RETA's rank also includes a short-term technical score of 81.
RETA has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on RETA!
Reata Pharmaceuticals Inc (RETA) stock has risen 0.03% while the S&P 500 is higher by 0.29% as of 12:38 PM on Monday, Sep 25. RETA is higher by $0.05 from the previous closing price of $172.32 on volume of 357,334 shares. Over the past year the S&P 500 is higher by 18.54% while RETA is higher by 650.41%. RETA lost -$2.99 per share in the over the last 12 months.
Click Here to get the full Stock Report for Reata Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter